ZELTIQ Announces Conference Call & Webcast of Fourth Quarter & Full Year 2013 Financial Results to be Held on February 25, 2014
February 10 2014 - 4:05PM
Marketwired
ZELTIQ Announces Conference Call and Webcast of Fourth Quarter and
Full Year 2013 Financial Results to be Held on February 25, 2014
PLEASANTON, CA--(Marketwired - Feb 10, 2014) - ZELTIQ® (NASDAQ:
ZLTQ), a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform, announced today that it
plans to release its fourth quarter and full year 2013 financial
results on Tuesday, February 25, 2013 after the market close.
ZELTIQ will hold a conference call on Tuesday, February 25,
2014, at 4:30 p.m. ET to discuss the results. The dial-in numbers
are (877) 280-7291 for domestic callers and (707) 287-9361 for
international callers. A live webcast of the conference call will
be available online from the investor relations page of the
Company's corporate website at www.coolsculpting.com.
After the live webcast, the call will remain available on
ZELTIQ's website, www.coolsculpting.com, until ZELTIQ releases its
first quarter 2014 financial results. In addition, a telephonic
replay of the call will be available until March 4, 2014. The
replay dial-in numbers are (855) 859-2056 for domestic callers and
(404) 537-3406 for international callers. Please use the
replay conference ID number 47860399.
About
ZELTIQ®
Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first
commercial product, the CoolSculpting System, is designed to
selectively reduce stubborn fat that may not respond to diet or
exercise. CoolSculpting is based on the scientific principle
that fat cells are more sensitive to cold than the overlying skin
and surrounding tissues. It utilizes patented technology of
precisely controlled cooling to reduce the temperature of fat cells
in the treated area, which is intended to cause fat cell
elimination through a natural biological process known as
apoptosis. ZELTIQ developed CoolSculpting to safely,
noticeably, and measurably reduce the fat layer.
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024